Data / Form D filings / NEUROPATHIX, INC.
NEUROPATHIX, INC.: Form D filings
NEUROPATHIX, INC., a biotechnology company in Doylestown, PA, filed 4 Form D notices with the SEC between 2017 and 2025. The latest, on November 17, 2025, reports an offering of $50 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3805 OLD EASTON ROAD, Doylestown, PA, 18902
- Phone
- (215) 695-6559
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1615999
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | New notice | $50,000,000 | $0 | $50,000,000 | 0 | Yet to occur | sec.gov |
| Feb 23, 2021 | New notice | $1,207,500 | $1,207,500 | 1 | Feb 17, 2021 | sec.gov | |
| Jan 14, 2020 | New notice | $3,000,000 | $100,000 | $2,900,000 | 1 | Dec 31, 2019 | sec.gov |
| Sep 5, 2017 | New notice | Indefinite | $0 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dean Petkanas | Executive Officer, Director |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Nov 17, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEUROPATHIX, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.